Literature DB >> 10679031

Progressive familial intrahepatic cholestasis: a personal perspective.

A S Knisely1.   

Abstract

Progressive familial intrahepatic cholestasis (PFIC), originally described as "Byler disease" in an Amish kindred, has been distinguished from other forms of cholestatic liver disease in childhood by clinical findings, clinical-laboratory observations, and morphologic studies in biopsy, hepatectomy, and autopsy specimens. Correlation with genetic analyses has permitted both more precise definition of PFIC and distinctions within PFIC. Two types of PFIC now are recognized: PFIC-1, resulting from mutations in a gene called FIC1 (familial intrahepatic cholestasis, type 1), and PFIC-2, resulting from mutations in a gene called BSEP (bile salt export pump). Other forms of PFIC may yet be identified. The roles of FIC1 and BSEP in the secretion of bile acids into bile and in the post-secretory modification of bile are under study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679031     DOI: 10.1007/s100240050016

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  9 in total

Review 1.  Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.

Authors:  Ralf Kubitz; Carola Dröge; Stefanie Kluge; Claudia Stross; Nathalie Walter; Verena Keitel; Dieter Häussinger; Jan Stindt
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

2.  Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.

Authors:  Renxue Wang; Jonathan A Sheps; Lin Liu; Jun Han; Patrick S K Chen; Jason Lamontagne; Peter D Wilson; Ian Welch; Christoph H Borchers; Victor Ling
Journal:  J Lipid Res       Date:  2018-11-11       Impact factor: 5.922

Review 3.  Genetics of familial intrahepatic cholestasis syndromes.

Authors:  S W C van Mil; R H J Houwen; L W J Klomp
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

4.  Human herpesvirus type 6 hepatitis or familiar intrahepatic cholestasis: the importance of follow-up.

Authors:  Valerio Nobili; Andrea Pietrobattista; Paola Francalanci; Ilaria Giovannoni; Matilde Marcellini; Sandro Vento
Journal:  BMJ Case Rep       Date:  2009-02-26

Review 5.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

6.  Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q.

Authors:  L N Bull; E Roche; E J Song; J Pedersen; A S Knisely; C B van Der Hagen; K Eiklid; O Aagenaes; N B Freimer
Journal:  Am J Hum Genet       Date:  2000-08-30       Impact factor: 11.025

7.  Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.

Authors:  Lee M Bass; Deepa Patil; M Sambasiva Rao; Richard M Green; Peter F Whitington
Journal:  BMC Gastroenterol       Date:  2010-03-13       Impact factor: 3.067

8.  FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells.

Authors:  Saori Koh; Tappei Takada; Ikuya Kukuu; Hiroshi Suzuki
Journal:  J Gastroenterol       Date:  2009-04-21       Impact factor: 7.527

Review 9.  Congenital cholestatic syndromes: what happens when children grow up?

Authors:  S C Ling
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.